OPKO Health, Inc.

OPK Healthcare Diagnostics & Research

OPKO Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.9 million, down 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS grew 94.7%, free cash flow grew 46.5% and total debt rose 6.37%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.53 0.08 −4.97%
Market cap
$1.2B
P/E
0.0×
Fwd P/E
−4.7×
Dividend yield
—
F-score
4/9
Altman Z
−0.42
Beneish M
−2.81
Dividend safety
n/a

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Net Income
(48.36) (305.25) (153.04) (314.92) 30.59 (30.14) (328.40) (188.86) (53.22) (225.68)
Depreciation & Amortization
96.81 102.32 97.53 94.80 86.21 79.50 109.82 106.52 100.15 96.86
Non Cash Items (Other)
3.53 62.50 4.51 116.41 20.29 9.46 80.75 32.35 (262.59) (8.54)
Accounts Receivable Change
(25.64) 58.01 20.40 7.38 (150.44) 5.23 128.60 3.41 (0.22) 30.21
Change in inventories
(6.61) (3.54) 4.59 (12.13) (77.64) 30.68 13.66 15.20 4.22 (4.12)
Accounts Payable Change
(19.82) 20.17 (26.08) 15.64 37.16 (10.85) (9.39) 2.83 (20.66) (14.22)
Change in payables and accrued liability
68.04 30.44 1.72 0.76 81.83 (33.72) (91.11) (5.48) 48.68 (47.84)
Change in other assets and liabilities
(35.91) (56.73) (58.76) (80.45) 11.48 (11.83) 0.89 5.84 0.16 (5.22)
Operating Cash Flow
32.05 (92.08) (109.14) (172.52) 39.48 38.34 (95.19) (28.20) (183.49) (178.54)
Capital expenditures
(17.15) (39.25) (26.63) (12.07) (33.44) 33.87 (22.63) (13.56) (24.77) (11.99)
Change in intangibles (net)
(5.00) — — — — — — — — —
Net Aquisitions
15.88 — — — — (4.00) (1.76) — — —
Short Term Investments Change (Net)
(0.01) 0.00 0.00 — 15.11 8.08 115.42 0.36 166.60 —
Long-Term Investments Change (Net)
(14.42) (7.41) 0.52 (1.20) 15.11 (2.00) — (4.64) 166.60 44.52
Other investing activities
— — — — — — — — 210.38 197.77
Investing cash flow
(20.70) (46.67) (26.12) (13.27) (18.33) 35.95 91.04 (18.20) 352.21 230.30
Repayment/Issuance of Debt (Net)
(43.77) 58.91 47.24 106.95 (35.83) (11.24) 23.75 (11.03) 287.98 (70.76)
Equity Repurchase (Common, Net)
8.58 2.13 93.67 76.06 0.76 1.08 (0.77) (0.27) (90.43) (47.30)
Other financial activities
70.06 46.63 39.83 (7.76) 5.50 (0.19) 156.31 — (13.38) —
Financing cash flow
(35.19) 61.04 140.91 175.25 (35.08) (10.35) 22.97 (11.30) 184.17 (118.06)
Exchange Rate Adjustment
(1.01) 0.47 (0.68) (0.48) 0.69 (1.44) (0.34) 0.39 (3.16) 3.43
Change in Cash
(24.86) (77.23) 4.97 (11.02) (13.24) 62.50 18.48 (57.31) 349.73 (62.87)
Beginning Cash
193.60 168.73 91.50 96.47 85.45 72.21 134.71 153.19 95.88 445.62
Ending Cash
168.73 91.50 96.47 85.45 72.21 134.71 153.19 95.88 445.62 382.74
Stock Based Compensation
42.69 28.31 21.76 13.42 8.95 13.63 18.51 11.41 11.05 10.71
Dividends Paid (Common)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(19.93) 48.35 (58.14) (68.81) (97.61) (20.48) 42.65 21.80 32.18 (41.18)
Investments Change (Net)
(14.43) (7.41) 0.52 (1.20) 15.11 6.08 115.42 (4.64) 166.60 44.52
Issuance/Purchase of Shares
8.58 2.13 93.67 76.06 0.76 1.08 (0.77) (0.27) (90.43) (47.30)
Other line items
Revenue per Employee
0.18 0.16 0.17 0.15 0.27 0.31 0.24 0.22 0.24 0.44

Fold the line items

In millions of $ except per-share values · columns are period end dates